Montag & Associates’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $527K | Hold |
6,825
| – | – | 0.02% | 299 |
|
|
2025
Q4 | $441K | Sell |
6,825
-1,870
| -22% | -$115K | 0.02% | 312 |
|
|
2025
Q3 | $556K | Sell |
8,695
-442
| -5% | -$30.9K | 0.03% | 296 |
|
|
2025
Q2 | $690K | Hold |
9,137
| – | – | 0.03% | 277 |
|
|
2025
Q1 | $813K | Hold |
9,137
| – | – | 0.04% | 260 |
|
|
2024
Q4 | $842K | Sell |
9,137
-1,425
| -13% | -$146K | 0.04% | 260 |
|
|
2024
Q3 | $1.19M | Hold |
10,562
| – | – | 0.06% | 231 |
|
|
2024
Q2 | $1.04M | Hold |
10,562
| – | – | 0.05% | 222 |
|
|
2024
Q1 | $1.07M | Buy |
10,562
+162
| +2% | +$14.2K | 0.05% | 237 |
|
|
2023
Q4 | $943K | Sell |
10,400
-850
| -8% | -$67.7K | 0.05% | 234 |
|
|
2023
Q3 | $873K | Sell |
11,250
-850
| -7% | -$70.5K | 0.06% | 232 |
|
|
2023
Q2 | $1.02M | Sell |
12,100
-1,175
| -9% | -$95.5K | 0.06% | 210 |
|
|
2023
Q1 | $1.13M | Sell |
13,275
-2,500
| -16% | -$215K | 0.07% | 194 |
|
|
2022
Q4 | $1.3M | Hold |
15,775
| – | – | 0.09% | 180 |
|
|
2022
Q3 | $1.13M | Buy |
15,775
+300
| +2% | +$27K | 0.08% | 188 |
|
|
2022
Q2 | $1.4M | Hold |
15,475
| – | – | 0.09% | 180 |
|
|
2022
Q1 | $1.73M | Hold |
15,475
| – | – | 0.09% | 181 |
|
|
2021
Q4 | $1.87M | Sell |
15,475
-1,175
| -7% | -$131K | 0.09% | 180 |
|
|
2021
Q3 | $1.68M | Hold |
16,650
| – | – | 0.09% | 180 |
|
|
2021
Q2 | $1.94M | Hold |
16,650
| – | – | 0.1% | 174 |
|
|
2021
Q1 | $1.83M | Hold |
16,650
| – | – | 0.1% | 173 |
|
|
2020
Q4 | $1.67M | Sell |
16,650
-9,075
| -35% | -$841K | 0.1% | 168 |
|
|
2020
Q3 | $2.01M | Buy |
25,725
+250
| +1% | +$18.8K | 0.16% | 130 |
|
|
2020
Q2 | $1.77M | Sell |
25,475
-3,200
| -11% | -$202K | 0.16% | 129 |
|
|
2020
Q1 | $1.34M | Sell |
28,675
-475
| -2% | -$30.5K | 0.13% | 140 |
|
|
2019
Q4 | $2.31M | Sell |
29,150
-150
| -0.5% | -$11.5K | 0.18% | 119 |
|
|
2019
Q3 | $2.16M | Sell |
29,300
-3,800
| -11% | -$273K | 0.19% | 113 |
|
|
2019
Q2 | $2.58M | Sell |
33,100
-100
| -0.3% | -$7.6K | 0.23% | 103 |
|
|
2019
Q1 | $2.52M | Buy |
33,200
+250
| +0.8% | +$19.9K | 0.23% | 106 |
|
|
2018
Q4 | $2.41M | Sell |
32,950
-4,000
| -11% | -$319K | 0.26% | 95 |
|
|
2018
Q3 | $3.54M | Sell |
36,950
-100
| -0.3% | -$9.91K | 0.31% | 81 |
|
|
2018
Q2 | $3.7M | Hold |
37,050
| – | – | 0.38% | 71 |
|
|
2018
Q1 | $3.91M | Hold |
37,050
| – | – | 0.4% | 70 |
|
|
2017
Q4 | $3.43M | Hold |
37,050
| – | – | 0.33% | 90 |
|
|
2017
Q3 | $3.35M | Buy |
37,050
+3,000
| +9% | +$255K | 0.36% | 84 |
|
|
2017
Q2 | $2.86M | Buy |
34,050
+1,875
| +6% | +$151K | 0.32% | 91 |
|
|
2017
Q1 | $2.6M | Buy |
32,175
+815
| +3% | +$64.1K | 0.29% | 97 |
|
|
2016
Q4 | $2.36M | Buy |
31,360
+6,700
| +27% | +$484K | 0.28% | 98 |
|
|
2016
Q3 | $1.67M | Sell |
24,660
-8,250
| -25% | -$554K | 0.21% | 122 |
|
|
2016
Q2 | $2.23M | Buy |
32,910
+300
| +0.9% | +$22K | 0.3% | 103 |
|
|
2016
Q1 | $2.35M | Sell |
32,610
-575
| -2% | -$37.7K | 0.33% | 91 |
|
|
2015
Q4 | $2.24M | Sell |
33,185
-1,900
| -5% | -$133K | 0.33% | 91 |
|
|
2015
Q3 | $2.27M | Sell |
35,085
-30,300
| -46% | -$2.24M | 0.36% | 91 |
|
|
2015
Q2 | $5.35M | Buy |
65,385
+36,350
| +125% | +$2.8M | 0.78% | 42 |
|
|
2015
Q1 | $2.01M | Sell |
29,035
-4,000
| -12% | -$289K | 0.29% | 107 |
|
|
2014
Q4 | $2.51M | Buy |
+33,035
| New | +$2.61M | 0.38% | 89 |
|
Other funds holding EMN
VPM
VCM
Montag & Associates's EMN Position: Q1 2026 in Review
Montag & Associates held its Eastman Chemical (EMN) position steady in Q1 2026 at 6,825 shares worth $527K. The position accounts for 0.02% of the portfolio, ranked #299.
Montag & Associates first reported a position in EMN in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.35M in Q2 2015. 634 funds tracked by Wall St. Rank hold EMN as of Q1 2026.
- Montag & Associates held 6,825 shares of Eastman Chemical worth $527K as of Q1 2026.
- Montag & Associates left its Eastman Chemical share count unchanged in Q1 2026.
- Eastman Chemical made up 0.02% of Montag & Associates's portfolio in Q1 2026, its #299 holding.
- Montag & Associates first reported a position in Eastman Chemical in Q4 2014 and has held it in 46 quarters since.
- Montag & Associates's Eastman Chemical position peaked at $5.35M in Q2 2015.
- 634 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2026.
Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.